Inactive

The USAMRICD is the nation's leading science and technology laboratory in medical chemical countermeasures research and development. USAMRICD manages a diversified portfolio of medical chemical warfar... The USAMRICD is the nation's leading science and technology laboratory in medical chemical countermeasures research and development. USAMRICD manages a diversified portfolio of medical chemical warfare agent research projects for the Department of Defense (DoD) and other Federal Agencies. USAMRICD’s strategic plan relies on the outstanding performance of scientists and support personnel and the ability to exceed expectations on customer directed research projects. CPD, RSD, USAMRICD, is an integral part of the research vision, providing support to researchers and their respective animal research protocols to study pathology associated with exposure to chemical, biological or kinetic warfare agents and a means to assess the efficacy of candidate therapeutics. One method of viewing tissue is scanning electron microscopy (SEM). Precision ion beam coating of organic or inorganic materials using coating materials such as carbon, gold/palladium, chromium, or platinum is required prior to imaging using a SEM analysis. A new Sputter Coater will fully support the USAMRICD mission. This is a combined synopsis/solicitation for commercial items prepared In Accordance With (IAW) the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested. Questions Due Date: Questions shall be submitted to the primary point-of-contact, Mrs. Marissa Manaway, marissa.c.manaway.civ@health.mil, and Mrs. Erin Maddox, erin.j.maddox.civ@health.mil, no later than 1:00 PM Eastern Daylight Time (EDT) on 13 August 2025. Questions received after this date and time will not be accepted or addressed. Quote Due Date: Quotes shall be submitted to the primary point-of-contact no later than 10:00 AM EDT on 21 August 2025. The POC for the delivery of the quote is the Contract Specialist, Mrs. Marissa Manaway, marissa.c.manaway.civ@health.mil. The Offeror is responsible for ensuring receipt of the quote by the POC. No telephone calls will be accepted. Please refer to the Attachments included for further details.